Clinical trial
Procalcitonin and C-Reactive Protein as Early Anastomotic Dehiscence Markers in Ovarian Cancer Surgery
NCT03131492 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procalcitonin and C-Reactive Protein as Early Anastomotic Dehiscence Markers in Ovarian Cancer Surgery
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2017
- Completion date
- July 31, 2021
- Enrollment
- 92 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anastomotic leak, ovarian neoplasms malignant